<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-122482</identifier>
<setSpec>0014-2565</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">How to prevent and treat pharmacological hypoglycemias</dc:title>
<dc:description xml:lang="en">A 58 year-old woman with type 2 diabetes diagnosed 3 years before came to our clinic. Her treatment was metformin 850mg every 12hours and glimepiride 4mg every 24hours. After the initiation of glimepiride 9 months before her weight has increased 5kg, and she suffers frequent hypoglycemias which have affected her while driving. Her BMI is 35.5kg/m2. She has a normal eye fund exam. She has hypertension treated with telmisartán and hidroclorotiazide with adequate control, and also hypercholesterolemia treated with atorvastatine 40mg every 24hours. Her blood test shows an HbA1c of 7.0%, normal values of microalbuminuria, total cholesterol 149mg/dl, HDL cholesterol 52mg/dl, LDL cholesterol 98mg/dl and triglycerides 123mg/dl. Her blood pressure is 129/81mmHg, there was no orthostatic hypotension, and her peripheral neurological examination shows normal results. In summary, our case is a young woman with type 2 diabetes and obesity, without chronic complications and which has frequent hypoglycaemia. How must this woman be evaluated and treated? (AU)</dc:description>
<dc:creator>Reyes García, R</dc:creator>
<dc:creator>Mezquita Raya, P</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Mujer de 58 años con diabetes tipo 2 diagnosticada hace 3 años, en tratamiento con metformina 850mg cada 12h y glimepirida 4mg cada 24h. Tras iniciar glimepirida hace 9 meses ha incrementado 5kg su peso habitual, y presenta hipoglucemias frecuentes que han afectado a su capacidad para conducir. Su índice de masa corporal es 35,5kg/m2. Presenta además hipertensión arterial en tratamiento con telmisartán e hidroclorotiazida con adecuado control, e hipercolesterolemia en tratamiento con atorvastatina 40mg/día. Acude a consulta para revisión, aporta fondo de ojo, con resultado normal y resultados de la analítica que muestra una HbA1c de 7,0%, microalbuminuria negativa, colesterol total 149mg/dl, HDL colesterol 52mg/dl, LDL colesterol 98mg/dl y triglicéridos 123mg/dl. La tensión arterial es de 129/81mmHg, no presenta hipotensión ortostática, y la exploración neurológica periférica en miembros inferiores es normal. En resumen, se trata de una paciente joven, con una diabetes tipo 2 y obesidad, sin complicaciones crónicas, y con hipoglucemias frecuentes ¿Cómo deber ser evaluada y tratada esta paciente? (AU)</dc:description>
<dc:source>Rev Clin Esp;214(4): 202-208, mayo 2014.</dc:source>
<dc:identifier>ibc-122482</dc:identifier>
<dc:title xml:lang="es">Como prevenir y tratar las hipoglucemias farmacológicas</dc:title>
<dc:subject>^d9951^s22012</dc:subject>
<dc:subject>^d3946^s22012</dc:subject>
<dc:subject>^d7181^s22054</dc:subject>
<dc:subject>^d8862^s22073</dc:subject>
<dc:subject>^d21012</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d9062</dc:subject>
<dc:subject>^d7182^s22020</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:type>article</dc:type>
<dc:date>201405</dc:date>
</metadata>
</record>
</ibecs-document>
